GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,940,000 | +13.5% | 180,062 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $6,997,000 | -0.1% | 183,141 | +4.1% | 0.00% | 0.0% |
| Q2 2021 | $7,006,000 | +29.5% | 175,949 | +16.1% | 0.00% | 0.0% |
| Q1 2021 | $5,409,000 | +2.9% | 151,574 | +6.0% | 0.00% | 0.0% |
| Q4 2020 | $5,258,000 | -9.4% | 142,929 | -7.3% | 0.00% | 0.0% |
| Q3 2020 | $5,804,000 | -19.4% | 154,226 | -12.6% | 0.00% | -50.0% |
| Q2 2020 | $7,198,000 | +2.2% | 176,481 | -5.1% | 0.00% | 0.0% |
| Q1 2020 | $7,045,000 | -70.8% | 185,956 | -63.8% | 0.00% | -33.3% |
| Q4 2019 | $24,106,000 | +220.1% | 513,006 | +190.7% | 0.00% | +50.0% |
| Q3 2019 | $7,530,000 | +20.8% | 176,451 | +13.3% | 0.00% | 0.0% |
| Q2 2019 | $6,233,000 | -49.2% | 155,769 | -46.9% | 0.00% | -33.3% |
| Q1 2019 | $12,265,000 | -62.2% | 293,493 | -65.4% | 0.00% | -40.0% |
| Q4 2018 | $32,432,000 | +114.8% | 848,794 | +125.8% | 0.01% | +25.0% |
| Q3 2018 | $15,100,000 | +77.4% | 375,921 | +78.0% | 0.00% | +33.3% |
| Q2 2018 | $8,512,000 | +19.3% | 211,177 | +15.6% | 0.00% | +50.0% |
| Q1 2018 | $7,134,000 | +38.2% | 182,602 | +25.5% | 0.00% | 0.0% |
| Q4 2017 | $5,161,000 | -42.0% | 145,521 | -33.6% | 0.00% | -33.3% |
| Q3 2017 | $8,896,000 | +22.1% | 219,126 | +29.7% | 0.00% | 0.0% |
| Q2 2017 | $7,283,000 | +33.8% | 168,918 | +30.8% | 0.00% | +50.0% |
| Q1 2017 | $5,444,000 | +60.2% | 129,145 | +46.3% | 0.00% | 0.0% |
| Q4 2016 | $3,399,000 | -15.9% | 88,287 | -5.8% | 0.00% | 0.0% |
| Q3 2016 | $4,041,000 | -0.3% | 93,697 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $4,055,000 | -7.9% | 93,579 | -13.9% | 0.00% | 0.0% |
| Q1 2016 | $4,405,000 | +7.0% | 108,632 | +6.4% | 0.00% | 0.0% |
| Q4 2015 | $4,117,000 | +23.1% | 102,067 | +17.3% | 0.00% | 0.0% |
| Q3 2015 | $3,344,000 | -6.0% | 86,979 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $3,556,000 | +10.1% | 85,391 | +22.0% | 0.00% | 0.0% |
| Q1 2015 | $3,229,000 | +15.3% | 69,970 | +6.7% | 0.00% | 0.0% |
| Q4 2014 | $2,800,000 | -16.4% | 65,548 | -10.1% | 0.00% | 0.0% |
| Q3 2014 | $3,350,000 | -13.1% | 72,895 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $3,856,000 | +80.0% | 72,122 | +79.8% | 0.00% | +100.0% |
| Q1 2014 | $2,142,000 | -7.2% | 40,110 | -7.3% | 0.00% | -50.0% |
| Q4 2013 | $2,309,000 | +415.4% | 43,266 | +384.6% | 0.00% | – |
| Q3 2013 | $448,000 | +0.4% | 8,929 | 0.0% | 0.00% | – |
| Q2 2013 | $446,000 | – | 8,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |